Prelude Therapeutics Incorporated (PRLD)
NASDAQ
3.88
+0.05 (+1.31%)
Real-time Data
01:30 PM
Day's Range
3.663.95
52 wk Range
1.156.83
Price Target - PRLD - Prelude Therapeutics Incorporated
Analyst Price Target
Where analysts expect the price to trade over the next twelve months.
Average‪$ 8.00‬
Current‪$ 3.88‬
Low ‪$ 6.00‬High ‪$ 10.00‬
Low‪$ 6.00‬
Average‪$ 8.00‬
Median‪$ 8.00‬
High‪$ 10.00‬
Implied move to the average target: +106.2%
Recommendations - PRLD - Prelude Therapeutics Incorporated
Analyst Ratings - PRLD - Prelude Therapeutics Incorporated
Analyst ratings
Items per row:
Estimates - PRLD - Prelude Therapeutics Incorporated
Estimate momentum
Current quarter · How the consensus estimate has moved over the last 90 days.
90 days ago-0.25
Now-0.17
Change+32.0%
Revised last month1/0
Growth estimates
Current quarter+54.9%
Next quarter+30.0%
Current year+58.1%
Next year-38.9%
Next 5 years (per year)-32.5%
Past 5 years (per year)-21.5%
EPS estimates
Earnings History - PRLD - Prelude Therapeutics Incorporated
Estimate surprises
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
